- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07692113
Kinetic Control Versus Dynamic Taping on First Metatarsophalangeal Joint in Athletes With Functional Hallux Limitus
July 2, 2026 updated by: Fatemah M. Alboraei, Cairo University
Kinetic Control Versus Dynamic Taping on First Metatarsophalangeal Joint Performance and Injury Prevention in Athletes With Functional Hallux Limitus: A Randomized Controlled Trial
This study is conducted to investigate and compare the effect of adding either kinetic control retraining or dynamic taping to the standard treatment program on first metatarsophalangeal joint dorsiflexion active range of motion, first metatarsophalangeal joint dorsiflexion strength, forefoot strike pattern running, vertical jump performance, and lower limb injury prevention in intermediate-professional level indoor sports athletes with functional hallux limitus.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
this study will be conducted, using valid and reliable methods and instrumentations, to evaluate and compare the effect of adding either kinetic control retraining or dynamic taping to the standard treatment program on first metatarsophalangeal joint dorsiflexion active range of motion, first metatarsophalangeal joint dorsiflexion strength, forefoot strike pattern running, vertical jump performance and lower limb injury prevention in indoor sports athletes with functional hallux limitus.
This may add a new hope to decrease the rate of injuries occurrence or recurrence which will diminish financial expenses and lengthen athletes' competitiveness time in courts.
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Fatemah Mahmoud Alboraei, master degree
- Phone Number: 00201010330474 00201550801318
- Email: fatemah.alboraei@gmail.com
Study Locations
-
-
Zahraa Almaady
-
Cairo, Zahraa Almaady, Egypt
- Recruiting
- Fatemah M. Alboraei
-
Contact:
- Fatemah Mahmoud Alboraei, Master Degree
- Phone Number: 00201550801318
- Email: fatemah.alboraei@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ninety male and female indoor sports' athletes at intermediate to professional level of indoor sports.
- Athletes aged from 18 to 35 years.
- Body Mass Index ranged from 22.5- 28 kg/cm2.
- Athletes with a habitual Fore Foot Strike Pattern by determining foot strike angle using Insole Pressure Sensors.
- Athletes with less than 37° of the first metatarsophalangeal joint dorsiflexion active range of motion using a Digital Goniometer (Positive Jack test).
- Athletes with less than 50° of the first metatarsophalangeal joint dorsiflexion active range of motion using a Digital Goniometer. (Positive flexor hallucis longus stretch text).
- Athletes with at least a 1.8-kg (4-lb) difference in first metatarsophalangeal joint dorsiflexion strength as compared to the opposite side using hand-held dynamometer.
- Athletes with pinch calluses, hyperkeratotic skin lesions identified by palpation on the medial surface of the affected first metatarsophalangeal joint (not the metatarsal head).
- Athlete's shoes must be with a minimal or no heel to toe drop design to facilitate Fore Foot Strike Pattern as Foot Strike Patterns may be facilitated partly by the shoe wear type.
- If any athlete changes the running shoes, it must be a safe transition for a few weeks to few months, to avoid injuries (stress fractures) or performance alteration.
Exclusion Criteria:
- Athletes with other habitual foot strike patterns rather than a forefoot strike pattern.
- Any limitation to the first metatarsophalangeal joint dorsiflexion active range of motion while resting plantar flexion position of the ankle.
- Athletes shoes that are cushioned with a high heel-to-toe drop which encourages Rearfoot Strike Pattern as foot strike patterns may be facilitated partly by the type of shoe wear.
- History of musculoskeletal system disorders (spine deformities, disc pathologies, orthopedic contractures, or osseous deformities such as: Sheperds fracture, Large steidas process, Ostrigonum Cysts and dorsal talar exostosis.
- History of surgeries in the last six months.
- History of neurological disorders.
- Any preexisting injury that may become exacerbated or made worse with participation.
- History of contact dermatitis or cutaneous adverse reaction to Dynamic Tape.
- Radiological signs as first metatarsophalangeal joint head alterations, dorsal or lateral spurs, and bunion formation, as mostly radiographs of Functional Hallux Limitus are normal and these signs are more relevant to hallux rigidus which will not be evaluated in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: standard treatment program
Thirty male & female athletes will receive the standard treatment program of Functional Hallux Limitus.
|
The text details therapeutic techniques for managing first metatarsophalangeal joint (1stMTPJ) issues, including: 1) First MTPJ Manipulation with Grade IV mobilization and thrusts; 2) Subtalar Manipulation to improve mobility; 3) 1stMTPJ Mobilization through Grade III dorsal glides; 4) Sesamoid Mobilization involving rhythmic oscillations; 5) Strengthening Exercises conducted three times daily to enhance stability; 6) Flexibility Exercises for related muscle groups; and 7) Sham Taping to simulate dynamic taping effects.
|
|
Experimental: standard treatment program and kinetic control
Thirty male & female athletes will receive kinetic control retraining added to the standard treatment program of Functional Hallux Limitus.
|
The text details therapeutic techniques for managing first metatarsophalangeal joint (1stMTPJ) issues, including: 1) First MTPJ Manipulation with Grade IV mobilization and thrusts; 2) Subtalar Manipulation to improve mobility; 3) 1stMTPJ Mobilization through Grade III dorsal glides; 4) Sesamoid Mobilization involving rhythmic oscillations; 5) Strengthening Exercises conducted three times daily to enhance stability; 6) Flexibility Exercises for related muscle groups; and 7) Sham Taping to simulate dynamic taping effects.
kinetic control retraining emphasizes achieving ideal lower limb (LL) sagittal alignment to activate the kinetic chain from hip to foot.
Key exercises include maintaining correct femur alignment, controlling knee movement, and focusing on eccentric control of various muscle groups.
Specific routines target hip (glutes), knee (popliteus), and ankle/foot levels (tibialis posterior, anterior, soleus, peroneus brevis) to enhance stability and extensibility.
Mobilization strategies address extensibility of gastrocnemius, peroneus longus, and toe flexors, ensuring functional alignment and proper loading techniques during exercises.
|
|
Experimental: standard treatment program and dynamic taping
Thirty male & female athletes will receive dynamic taping retraining added to the standard treatment program of Functional Hallux Limitus.
|
The text details therapeutic techniques for managing first metatarsophalangeal joint (1stMTPJ) issues, including: 1) First MTPJ Manipulation with Grade IV mobilization and thrusts; 2) Subtalar Manipulation to improve mobility; 3) 1stMTPJ Mobilization through Grade III dorsal glides; 4) Sesamoid Mobilization involving rhythmic oscillations; 5) Strengthening Exercises conducted three times daily to enhance stability; 6) Flexibility Exercises for related muscle groups; and 7) Sham Taping to simulate dynamic taping effects.
Athletes will receive a briefing on the taping procedure before it starts, with the option for private administration.
The functional correction technique is to be applied to limit first metatarsophalangeal joint plantar flexion.
This involves measuring and applying an I-shaped strip of tape from the plantar surface over the toenail to the first metatarsophalangeal joint, ensuring no tension at the joint's base.
The athlete's toe should be positioned in maximum plantar flexion while severe tension (150-200%) is applied, followed by laying down a J strip on the dorsum of the joint.
The remaining tape should be placed with no tension, approximately one inch below the first metatarsophalangeal joint.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of active range of motion of the First metatarsophalangeal joint dorsiflexion
Time Frame: (pre-intervention) and after 4 weeks (post-intervention)
|
A digital goniometer will be utilized to measure the first metatarsophalangeal joint dorsiflexion same positions and will be marked in 1° increments.
For the first metatarsophalangeal joint dorsiflexion measurements, a pen will be used to draw lines bisecting the first metatarsophalangeal joint and hallux and to mark the estimated metatarsophalangeal joint center.
|
(pre-intervention) and after 4 weeks (post-intervention)
|
|
Assessment of muscle strength of the First metatarsophalangeal joint dorsiflexion
Time Frame: (pre-intervention) and after 4 weeks (post-intervention)
|
Toe dynamometry is an objective tool used to measure toe flexor strength.
The 'make' technique was used in all studies whereby the dynamometer is held stationary by a physical therapist or an external attachment and the athlete maximally push down onto the dynamometer with his First metatarsophalangeal joint
|
(pre-intervention) and after 4 weeks (post-intervention)
|
|
Forefoot running (step length, speed and propulsion rate)
Time Frame: (pre-intervention) and after 4 weeks (post-intervention)
|
therapist will place the Digitsole Pro system of intelligent pressure sensors and Digitsole pods in athletes' shoes to export data while running for 5 minutes after a sufficient warm-up for eight minutes of jogging.
A compiled running performance data analysis of step length, speed, and propulsion rate will show in the form of dashboards through the Digitsole Pro® applications on an external tablet or mobile device.
|
(pre-intervention) and after 4 weeks (post-intervention)
|
|
Vertical jumping performance (flight time, vertical jump height, and takeoff velocity)
Time Frame: (pre-intervention) and after 4 weeks (post-intervention)
|
PT will Place the Digitsole Pro system of ntelligent pressure sensors and Digitsole pods in athletes' shoes to export data while dynamic vertical jumb for 5 minutes after a sufficient warm up for eight minutes of jogging.
A compiled vertical jumb performance data analysis of flight time, vertical jump height and tack-off velocity will show in the form of dashboards through the Digitsole Pro® applications on an external tablet or mobile device.
|
(pre-intervention) and after 4 weeks (post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 25, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 30, 2026
Study Registration Dates
First Submitted
March 6, 2026
First Submitted That Met QC Criteria
July 2, 2026
First Posted (Actual)
July 9, 2026
Study Record Updates
Last Update Posted (Actual)
July 9, 2026
Last Update Submitted That Met QC Criteria
July 2, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/006173
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hallux Limitus
-
Stryker Trauma GmbHCompletedOsteoarthritis | Rheumatoid Arthritis | Bunion | Hallux Limitus of Left Great Toe | Arthritis of 1st Metatarsophalangeal Joint | Hallux Limitus of Right Great ToeItaly
-
Hyalex Orthopaedics, Inc.Recruiting
-
Peking University Third HospitalNot yet recruitingChronic Plantar Fasciitis | Functional Hallux Limitus
-
Golden Jubilee National HospitalUnknownHallux Valgus | Hallux RigidusUnited Kingdom
-
University of Wisconsin, MadisonTerminated
-
University Hospital, GhentWithdrawn
-
Tampere University HospitalUnknownHallux Valgus | Hallux RigidusFinland
-
Artimplant ABUnknown
-
LabrhaCompletedHallux Rigidus, Unspecified FootFrance
-
Nova Scotia Health AuthorityRecruitingHallux Valgus | Hallux RigidusCanada
Clinical Trials on the standard treatment
-
Jimma UniversityEthiopian Society of Cardiac ProfessionalsRecruiting
-
Institut Claudius RegaudCompleted
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityCompleted
-
University of PisaAzienda Ospedaliero, Universitaria Pisana; Fondazione Don Carlo Gnocchi Onlus; Ospedale Policlinico San Martino and other collaboratorsNot yet recruiting
-
Richard CrosbyNational Institute of Mental Health (NIMH)CompletedSexually Transmitted Diseases | HIV
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityNot yet recruiting
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityNot yet recruitingBladder Cancer | Renal CancerBelarus
-
Institute of Biophysics and Cell Engineering of...The Republican Center for Research and Practice in OtolaryngologyNot yet recruitingAllergic Rhinitis | Rhinosinusitis Chronic
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityCompletedSystemic Lupus ErythematosusBelarus
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityEnrolling by invitationAge-Related Macular DegenerationBelarus